Search

everythinglearnresearchcommunity

for

Search:↓

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Red light at 627 nm can safely trigger IL-4 release in skin cells, potentially helping treat inflammatory skin conditions.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

A mutation in the iRhom2 gene causes hairless mice due to abnormal hair follicle development.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

RXRα is crucial for proper immune response and links diet to immune function.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

IL-9/IL-9R signaling can negatively affect human hair growth and may be a target for treating hair loss conditions.

CD2 might be a new treatment target for patchy alopecia areata.

The protein EZH2 blocks microRNA-22, increasing STK40 protein, which helps hair follicle stem cells change and grow hair.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

IL-36α helps in growing new hair follicles when healing wounds, potentially aiding in hair growth.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

IL-10 may worsen alopecia areata instead of helping it.

IL-1β inhibits human hair follicle growth.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Dupilumab improves eczema in Netherton Syndrome but not ichthyosis linearis circumflexa.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.